Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) has scheduled a conference call for 4th November 2020 at 11:30 AM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.ionispharma.com
Earnings Expectation
Ionis Pharmaceuticals, Inc. is set to announce third quarter earning results on Wednesday 4th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, IONS to report 3Q20 loss of $ 0.09 per share. For the full year, analysts anticipate top line of $ 708.95 million, while looking forward to loss of $ 0.51 per share bottom line.
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; and TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
